PMC:7394275 / 10859-11247 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T178","span":{"begin":202,"end":207},"obj":"UBERON:0000178"},{"id":"T179","span":{"begin":252,"end":263},"obj":"UBERON:0001004"},{"id":"T90815","span":{"begin":202,"end":207},"obj":"UBERON:0000178"},{"id":"T48524","span":{"begin":252,"end":263},"obj":"UBERON:0001004"}],"text":"ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].\nThe treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":202,"end":207},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].\nThe treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T13","span":{"begin":202,"end":207},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].\nThe treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"349","span":{"begin":111,"end":119},"obj":"Species"},{"id":"373","span":{"begin":99,"end":110},"obj":"Disease"},{"id":"400","span":{"begin":361,"end":380},"obj":"Disease"}],"attributes":[{"id":"A349","pred":"tao:has_database_id","subj":"349","obj":"Tax:9606"},{"id":"A373","pred":"tao:has_database_id","subj":"373","obj":"MESH:D009503"},{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].\nThe treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T132","span":{"begin":145,"end":151},"obj":"Disease"},{"id":"T133","span":{"begin":361,"end":371},"obj":"Disease"}],"attributes":[{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A133","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].\nThe treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T55","span":{"begin":194,"end":198},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T56","span":{"begin":202,"end":207},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T57","span":{"begin":202,"end":207},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].\nThe treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society"}